Membrane changes and adenosine triphosphate content in normal and malignant transformed cells.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMC 433595)

Published in Proc Natl Acad Sci U S A on June 01, 1973

Authors

I Vlodavsky, M Inbar, L Sachs

Articles cited by this

Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91

Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO. Proc Natl Acad Sci U S A (1962) 14.59

Use of the liquid scintillation spectrometer for determining adenosine triphosphate by the luciferase enzyme. Anal Biochem (1969) 7.65

The dynamic state of the lymphocyte membrane. Factors affecting the distribution and turnover of surface immunoglobulins. Eur J Immunol (1972) 7.05

Identification of Hemagglutinin of Jack Bean with Concanavalin A. J Bacteriol (1936) 6.29

A difference in the architecture of the surface membrane of normal and virally transformed cells. Proc Natl Acad Sci U S A (1969) 6.03

Interaction of the carbohydrate-binding protein concanavalin A with normal and transformed cells. Proc Natl Acad Sci U S A (1969) 5.39

Structural difference in sites on the surface membrane of normal and transformed cells. Nature (1969) 3.81

The covalent and three-dimensional structure of concanavalin A. Proc Natl Acad Sci U S A (1972) 3.09

Unusual fragments in the subunit structure of concanavalin A. Proc Natl Acad Sci U S A (1971) 2.62

Topography of membrane concanavalin A sites modified by proteolysis. Nat New Biol (1972) 2.04

Differential toxicity on normal and transformed cells in vitro and inhibition of tumour development in vivo by concanavalin A. Nature (1970) 1.64

Studies on the mechanism of the inhibition of protein synthesis induced by intracellular ATP depletion. Biochim Biophys Acta (1971) 1.37

Inhibition of ascites tumor development by concanavalin A. Int J Cancer (1972) 1.36

Differences in the binding of fluorescent concanavalin A to the surface membrane of normal and transformed cells. Proc Natl Acad Sci U S A (1972) 1.20

A specific metabolic activity on the surface membrane in malignant cell-transformation. Proc Natl Acad Sci U S A (1971) 1.19

Temperature-sensitive activity on the surface membrane in the activation of lymphocytes by lectins. Exp Cell Res (1973) 1.07

Requirement for cell replication after SV40 infection for a structural change of the cell surface membrane. Virology (1970) 1.02

Protein labeling by acetylation. Biopolymers (1972) 1.00

The mechanism of cell fusion. I. Energy requirements for virus-induced fusion of Ehrlich ascites tumor cells. J Biol Chem (1972) 0.98

Mapping of sites on the surface membrane of mammalian cells. II. Relationship of sites for concanavalin A and an ornithine, leucine copolymer. J Membr Biol (1972) 0.81

Articles by these authors

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (1991) 9.21

The cloning of normal "mast" cells in tissue culture. J Cell Physiol (1965) 5.47

Interaction of the carbohydrate-binding protein concanavalin A with normal and transformed cells. Proc Natl Acad Sci U S A (1969) 5.39

Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci U S A (1987) 4.83

Characterization of the simian virus 40-specific RNA in virus-yielding and transformed cells. J Mol Biol (1968) 4.65

The induction of cellular DNA synthesis by simian virus 40 in contact-inhibited and in x-irradiated cells. Proc Natl Acad Sci U S A (1966) 4.64

In vitro transformation of normal cells to tumor cells by carcinogenic hydrocarbons. J Natl Cancer Inst (1965) 4.53

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann Oncol (2004) 4.52

In vitro control of the development of macrophage and granulocyte colonies. Proc Natl Acad Sci U S A (1966) 4.13

Structural difference in sites on the surface membrane of normal and transformed cells. Nature (1969) 3.81

A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. Am J Pathol (1988) 3.72

The induction of clones of normal mast cells by a substance from conditioned medium. Exp Cell Res (1966) 3.01

Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia. Nature (1978) 2.97

Microviscosity parameters and protein mobility in biological membranes. Biochim Biophys Acta (1976) 2.95

The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem (1992) 2.85

In vitro cell transformation by x-irradiation. Nature (1966) 2.75

Permissive effect of the extracellular matrix on cell proliferation in vitro. Proc Natl Acad Sci U S A (1980) 2.71

Induction of colony formation in vitro by human lymphocytes. Nature (1976) 2.71

On the mechanism of polyoma virus-induced synthesis of cellular DNA. Proc Natl Acad Sci U S A (1965) 2.67

Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry (1989) 2.49

Difference in microviscosity induced by different cholesterol levels in the surface membrane lipid layer of normal lymphocytes and malignant lymphoma cells. J Mol Biol (1974) 2.48

Destruction of mouse and rat embryo cells in tissue culture by lymph node cells from unsensitized rats. J Cell Physiol (1965) 2.44

Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med (1998) 2.42

Specific inhibition by N-acetyl-D-galactosamine of the interaction between soybean agglutinin and animal cell surfaces. Biochim Biophys Acta (1970) 2.33

Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci U S A (1990) 2.25

In vitro induction of granulocyte differentiation in hematopoietic cells from leukemic and non-leukemic patients. Proc Natl Acad Sci U S A (1970) 2.22

Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion. Proc Natl Acad Sci U S A (1979) 2.17

VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem (1997) 2.12

Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc Natl Acad Sci U S A (1996) 2.12

Cervical competence as a continuum: a study of ultrasonographic cervical length and obstetric performance. Am J Obstet Gynecol (1995) 2.10

Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc Natl Acad Sci U S A (2001) 2.10

Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis. Cancer Res (1983) 2.04

Heparanase as mediator of angiogenesis: mode of action. FASEB J (2001) 2.04

Identification of mutagenic metabolites of benzo(a)pyrene in mammalian cells. Proc Natl Acad Sci U S A (1976) 1.96

Morphological appearance, growth behavior and migratory activity of human tumor cells maintained on extracellular matrix versus plastic. Cell (1980) 1.94

Hybridization between SV40 DNA and cellular DNA's. J Mol Biol (1969) 1.92

Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood (1993) 1.90

Cell susceptibility to transformation and cytotoxicity by the carcinogenic hydrocarbon benzo[a]pyrene. Proc Natl Acad Sci U S A (1966) 1.86

Control of lysozyme induction in the differentiation of myeloid leukemic cells. Cell (1976) 1.79

Reversion of properties in cells transformed by polyoma virus. Nature (1968) 1.79

Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix. J Biol Chem (1995) 1.78

DNA rearrangement of a homeobox gene in myeloid leukaemic cells. EMBO J (1988) 1.75

Biotype-dependent secondary symbiont communities in sympatric populations of Bemisia tabaci. Bull Entomol Res (2007) 1.72

Expression of basic fibroblast growth factor in normal human tissues. Lab Invest (1990) 1.70

Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria. Kidney Int (2007) 1.70

The continued requirement for inducer for the development of macrophage and granulocyte colonies. J Cell Physiol (1968) 1.67

Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res (2001) 1.67

Receptor mobility and the mechanism of cell-cell binding induced by concanavalin A. Proc Natl Acad Sci U S A (1974) 1.65

An analysis of the mechanism of neoplastic cell transformation by polyoma virus, hydrocarbons, and x-irradiation. Curr Top Dev Biol (1967) 1.64

Differential toxicity on normal and transformed cells in vitro and inhibition of tumour development in vivo by concanavalin A. Nature (1970) 1.64

Chromosome mapping of the genes that control differentiation and malignancy in myeloid leukemic cells. Proc Natl Acad Sci U S A (1977) 1.64

The in vitro induction of an increase in cell multiplication and cellular life span by the water-soluble carcinogen dimethylnitrosamine. Proc Natl Acad Sci U S A (1968) 1.60

The difference in contact inhibition of cell replication between normal cells and cells transformed by different carcinogens. Proc Natl Acad Sci U S A (1966) 1.59

Respective roles of laminin and fibronectin in adhesion of human carcinoma and sarcoma cells. Nature (1981) 1.59

Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Regul (1990) 1.55

Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies. Leukemia (2007) 1.54

A two-domain mechanism for group A streptococcal adherence through protein F to the extracellular matrix. EMBO J (1996) 1.54

A comparison of the binding of epidermal growth factor to cultured granulosa and luteal cells. J Biol Chem (1978) 1.53

Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis. Am J Pathol (2000) 1.52

Effects of extracellular matrix on the response of endothelial cells to radiation in vitro. Eur J Cancer (1992) 1.51

Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth Differ (1993) 1.50

Ciromosomal control of reversion in transformed cells. Nature (1971) 1.48

Mutability of different genetic loci in mammalian cells by metabolically activated carcinogenic polycyclic hydrocarbons. Proc Natl Acad Sci U S A (1976) 1.47

Different blocks in the differentiation of myeloid leukemic cells. Proc Natl Acad Sci U S A (1974) 1.47

Substrate specificity of heparanases from human hepatoma and platelets. J Biol Chem (1998) 1.47

The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6. Blood (1988) 1.47

A theory on the mechanism of carcinogenesis by small deoxyribonucleic acid tumour viruses. Nature (1965) 1.45

Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet-derived growth factor-like protein which is secreted. J Cell Physiol (1987) 1.44

Control of the reversion of properties in transformed cells. Nature (1970) 1.44

Heparanase neutralizes the anticoagulation properties of heparin and low-molecular-weight heparin. J Thromb Haemost (2006) 1.44

Control of normal differentiation of myeloid leukemic cells. VIII. Induction of differentiation to mature granulocytes in mass culture. J Cell Physiol (1975) 1.42

Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase. Nature (1984) 1.42

Cell susceptibility to transformation by x-irradiation and fixation of the transformed state. Proc Natl Acad Sci U S A (1967) 1.41

Rotational relaxation time of concanavalin A bound to the surface membrane of normal and malignant transformed cells. J Mol Biol (1973) 1.40

Mobility of carbohydrate containing sites on the surface membrane in relation to the control of cell growth. FEBS Lett (1973) 1.39

Regulation of membrane changes, differentiation, and malignancy in carcinogenesis. Harvey Lect (1974) 1.39

[CFS, the condition with the thousands different names. "The tired nomad"--a modern epidemic?]. Lakartidningen (1994) 1.38

Ion metabolism in a Halobacterium. I. Influence of age of culture on intracellular concentrations. J Gen Physiol (1970) 1.38

Mutagenesis and transformation of normal cells by chemical carcinogens. Nature (1976) 1.37

Role of contact inhibition in the regulation of receptor-mediated uptake of low density lipoprotein in cultured vascular endothelial cells. Proc Natl Acad Sci U S A (1978) 1.36

Inhibition of ascites tumor development by concanavalin A. Int J Cancer (1972) 1.36

Control of normal differentiation of myeloid leukemic cells to macrophages and granulocytes. Proc Natl Acad Sci U S A (1973) 1.36

Constitutive uncoupling of pathways of gene expression that control growth and differentiation in myeloid leukemia: a model for the origin and progression of malignancy. Proc Natl Acad Sci U S A (1980) 1.35

Induction of virus synthesis in polyoma transformed cells by ultraviolet light and mitomycin C. Virology (1970) 1.34

Enzymatic hydroxylation of benzopyrene and its relationship to cytotoxicity. Proc Natl Acad Sci U S A (1969) 1.33

Effects of irradiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells. Cancer Res (1989) 1.33

Cell-mediated mutagenesis of mammalian cells with chemical carcinogens. Int J Cancer (1974) 1.32

Genetic dissection of the control of normal differentiation in myeloid leukemic cells. Proc Natl Acad Sci U S A (1977) 1.32

Increase of cholesterol level in the surface membrane of lymphoma cells and its inhibitory effect on ascites tumor development. Proc Natl Acad Sci U S A (1974) 1.30

The stimulation of tumor cell growth by a substance produced by normal and tumor cells. J Cell Physiol (1969) 1.30

Formation of bone tissue in culture from isolated bone cells. J Cell Biol (1974) 1.30

The activation of virus synthesis in polyoma-transformed cells. Virology (1969) 1.28

Induction of specific changes in the surface membrane of myeloid leukemic cells by steroid hormones. Int J Cancer (1975) 1.28

Receptor mobility and the binding of cells to lectin-coated fibers. J Cell Biol (1975) 1.27